Office of Infectious Diseases
BSC Member Profiles
Ruth L. Berkelman, MD
Rollins Professor, Director of the Center for Public Health Preparedness and Research, and Director of the Emory Preparedness and Emergency Response Research Center, Emory University, Atlanta, Georgia
Dr. Berkelman is Rollins Professor and the Director of the Center for Public Health Preparedness and Research at Emory University, and a globally recognized expert in public health, infectious diseases, and disease surveillance. She began her public health career as an Epidemic Intelligence Service officer at the Centers for Disease Control and Prevention, and later served as Deputy Director of the National Center for Infectious Diseases and as a Senior Advisor to the Director, achieving the rank of Assistant Surgeon General in the U.S. Public Health Service. Among her national leadership roles, Dr. Berkelman has served as chair of the Public and Scientific Affairs Board of the American Society for Microbiology, and as a trustee at Princeton University. She is a member of the Institute of Medicine of the National Academies and was appointed in 2007 to the National Biodefense Science Board. Dr. Berkelman is chair of the BSC, OID.
Kristy K. Bradley, DVM, MPH
State Epidemiologist and State Public Health Veterinarian, Oklahoma State Department of Health, Oklahoma City
Dr. Bradley, State Epidemiologist and State Public Health Veterinarian at the Oklahoma State Department of Health, has extensive experience in the prevention and control of infectious diseases, with particular focus on diseases transmitted from animals to humans. In her current position, she has provided consultation to other health professionals and the public on infectious diseases and has helped lead the state’s bioterrorism preparedness and response programs. Dr. Bradley also serves as an adjunct assistant professor in the College of Veterinary Medicine at Oklahoma State University and in the College of Public Health at the University of Oklahoma Health Sciences Center. Dr. Bradley has earned diplomat status in the American College of Veterinary Preventive Medicine and serves in several professional associations, including the Infectious Disease Steering Committee of the Council of State and Territorial Epidemiologists.
Harry L. Chen, MD
Commissioner, Vermont Department of Health, Burlington
Dr. Chen, Health Commissioner of Vermont, is nationally recognized for his public health expertise and perspective on healthcare transformation and electronic health records. He has extensive legislative experience, including as a three-term state representative in Vermont, serving his final term as Vice Chair of the House Committee on Health Care. In addition, Dr. Chen has more than 20 years’ experience as an emergency physician at Rutland (Vermont) Regional Medical Center, where he was Medical Director for approximately 6 years, and is on the clinical faculty at the University of Vermont College of Medicine. Additional expertise includes serving as vice chair of the Vermont Board of Medical Practice, as interim executive director of the Vermont Program for Quality in Health Care, and as a member of the Electronic Health Record Selection Workgroup, Vermont Information Technology Leaders.
Franklin R. Cockerill, III, MD
Chair, Department of Laboratory Medicine and Pathology, Mayo Clinic, and President and CEO, Mayo Medical Laboratories, Rochester, Minnesota
Dr. Cockerill is Chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and serves as Chief Executive Officer of Mayo Medical Laboratories, a global reference laboratory operating within Mayo Clinic. He is also the Ann and Leo Markin Professor of Microbiology and Medicine at the Mayo Clinic College of Medicine, with extensive experience and expertise in infectious diseases and antimicrobial resistance. Dr. Cockerill is board certified in Internal Medicine and Infectious Diseases by the American Board of Internal Medicine and in Medical Microbiology by the American Board of Pathology. In addition to his Mayo administrative assignments, Dr. Cockerill currently holds several high-profile extramural leadership positions, including chair of the Subcommittee on Antimicrobial Susceptibility Testing, Clinical and Laboratory Standards Institute (CLSI); council member and chair-elect of the Program Committee of the Association for Molecular Pathology (AMP); and director, Board of Directors of the American Clinical Laboratory Association (ACLA). He also recently served as chair, Microbiology Devices Panel of the Medical Devices Advisory Committee of the US Food and Drug Administration (FDA), and editor, Journal of Clinical Microbiology.
James Hadler, MD, MPH
Public Health Consultant, New Haven, Connecticut
Dr. Hadler is an infectious disease and epidemiology consultant to the Connecticut and Yale Emerging Infections Programs, the New York City Department of Health and Mental Hygiene, and the Council of State and Territorial Epidemiologists. From 1984-2008, he served as State Epidemiologist and Director of infectious disease surveillance and control with the Connecticut Department of Public Health, overseeing investigations into emerging and reemerging diseases such as HIV, multidrug-resistant tuberculosis, West Nile virus, anthrax, SARS, shiga-toxin–producing Escherichia coli, and methicillin-resistant Staphylococcus aureus (MRSA), and evaluating the impact of new vaccines on the epidemiology of their target diseases.
Tracy Ann Lieu, MD, MPH
Director, Division of Research, Kaiser Permanente of Northern California, Oakland
Dr. Lieu, Director of the Division of Research at Kaiser Permanente of Northern California, is a nationally recognized leader in child health services research. She previously served as Professor and Director of the Center for Child Health Care Studies at Harvard Medical School and Harvard Pilgrim Health Care Institute, and also practiced as a part-time pediatrician with Harvard Vanguard Medical Associates. Dr. Lieu has made important contributions to public health in the areas of vaccine safety, economics, and delivery. She is a leader in multi-center national systems for active post-licensure monitoring of vaccine safety for CDC and the U.S. Food and Drug Administration. Her national roles have included membership on the U.S. Preventive Services Task Force and the Advisory Committee on Immunization Practices, and serving as the chair of the Health Services Organization and Delivery study section of the National Institutes of Health.
Laurene Mascola, MD, MPH, FAAP
Chief, Acute Communicable Disease Control Program, Los Angeles County Department of Public Health, California
Dr. Mascola is Chief of the Acute Communicable Disease Control Program of the Los Angeles County Department of Public Health. She attended St. Louis University Medical School and earned her Master of Public Health degree from UCLA. She completed her pediatric residency at Children’s Hospital Los Angeles and completed residency and fellowship programs in preventive medicine. Dr. Mascola is a pediatrician and a member of the Alpha Omega Alpha Honor Medical Society. She served as an Epidemic Intelligence Service officer at CDC and was a field officer in Los Angeles County. She worked internationally for the World Health Organization in Ethiopia, and she has provided consultations in Brazil, Nepal, and Mongolia. Dr. Mascola has extensive experience in epidemiology and infectious disease prevention and control, publishing more than 100 articles and book chapters. She is a recipient of many honors and awards, including CDC/ATSDR Charles C. Shepard Science Awards, a Certificate of Appreciation from the U.S. Food and Drug Administration, and the American Academy of Pediatrics’ Outstanding Achievement in the Application of Epidemiologic Information to Child Health Advocacy Award in 2009, from the Section on Epidemiology and the Council on Community Pediatrics. In summer 2009, she was elected by the Council of State and Territorial Epidemiologists to be the chair of the Infectious Diseases Steering Committee, and became president-elect in 2011.
José Thier Montero, MD, MHCDS
Director, Division of Public Health Services, New Hampshire Department of Health and Human Services, Concord
Dr. Montero is Director of the Division of Public Health Services at the New Hampshire Department of Health and Human Services and has extensive experience in public health leadership and the prevention and control of infectious diseases. His major research interests include
vaccine-preventable diseases, epidemic response and preparedness, and the integration of public health and population approaches in clinical practice. In his current position, Dr. Montero leads the delivery of high-quality, evidence-based services and prompt response to public health threats and emerging issues in New Hampshire. Previous positions include Chief of the Bureau of Communicable Disease Control, State Epidemiologist, and Deputy Director for Public Health Emergency Preparedness and Response. Dr. Montero also holds national and regional committee leadership positions, including president of the Board of Directors of the Association of State and Territorial Health Officials (ASTHO) and chair of ASTHO’s Infectious Diseases Policy Committee. In addition, he holds adjunct assistant professorships in the School of Health and Human Services at the University of New Hampshire and in the Department of Community and Family Medicine at the Geisel School of Medicine at Dartmouth College.
Andrew Tobias Pavia, MD
George and Esther Gross Presidential Professor and Chief, Division of Pediatric Infectious Diseases, University of Utah, Salt Lake City
Dr. Pavia is George and Esther Gross Presidential Professor and Chief of the Division of Pediatric Infectious Diseases at the University of Utah and Hospital Epidemiologist at Primary Children’s Medical Center. He has extensive experience in the prevention and control of infectious diseases, with particular expertise in pediatrics, vaccines, and public health preparedness. His research interests include the epidemiology of influenza and other respiratory infections; vaccine-preventable diseases; diarrheal diseases; and HIV/AIDS, with special interest in the treatment of HIV in women and children and the prevention of mother-to-child transmission of HIV. Dr. Pavia has served on federal and state advisory committees on vaccine policy, biodefense, and pandemic influenza preparedness—including as a past chair of the Vaccine Safety Working Group of the National Vaccine Advisory Committee, current chair of the Pandemic Influenza Task Force of the Infectious Diseases Society of America (IDSA), and Board of Directors liaison to the National and Global Public Policy Committee of IDSA.
Scott C. Ratzan, MD, MPA
Vice President, Global Corporate Affairs, Anheuser-Busch InBev, New York, New York
Dr. Ratzan, Vice President, Global Corporate Affairs, Anheuser-Busch InBev, has made major contributions to improve public health domestically and internationally. In his current role, he is charged with advancing public health policy through communication, health diplomacy, and innovative programs to improve lives. He is a pioneer in the areas of health literacy and mobile health (mHealth) communication, including the invention of the Digital Health Score, a single health literacy metric for noncommunicable disease prevention and care. Additionally, Dr. Ratzan is the Editor-in-Chief of the peer-reviewed Journal of Health Communication: International Perspectives, serves as co-chair of the United Nations Secretary General’s Every Woman Every Child Innovation Working Group, is a member of the US Institute of Medicine (IOM) Roundtable on Health Literacy, serves on the World Economic Forum Global Agenda Council on Well-Being and Mental Health, and is a former Ambassador for global health research selected by Research!America. Dr. Ratzan maintains faculty appointments at Columbia University Mailman School of Public Health, Tufts University School of Medicine, and The George Washington University School of Public Health and Health Services.
Mathuram Santosham, MD, MPH
Director, Center for American Indian Health, Department of International Health, The Johns Hopkins University, Baltimore, Maryland
Dr. Santosham is a Professor of Pediatrics and International Health at The Johns Hopkins University. He is also the Director of the Center for American Indian Health in the Department of International Health at Johns Hopkins. Regarded throughout the world as an expert in oral rehydration therapy and childhood vaccines, Dr. Santosham serves on numerous national and international committees on these and related subjects. As part of these efforts, Dr. Santosham has made major contributions worldwide regarding the introduction of Haemophilus influenzae type b (Hib) vaccine as part of routine vaccination programs.
Susan Elaine Sharp, PhD
Medical Director of Airport Way Regional and Sunnyside Medical Center Laboratories and Regional Director of Microbiology, Department of Pathology, Kaiser Permanente Northwest, Portland, Oregon
Dr. Sharp is Medical Director of Airport Way Regional and Sunnyside Medical Center Laboratories as well as Regional Director of Microbiology for Kaiser Permanente Northwest. She is highly regarded nationally and internationally as a leader in clinical microbiology. At Kaiser Permanente, she oversees the daily operations of the microbiology laboratory and routinely consults with clinicians regarding interpretation of complex laboratory data. She also serves as an Affiliate Associate Professor in the Department of Pathology, School of Medicine, Oregon Health and Sciences University, and has presented numerous lectures, seminars, and workshops locally, nationally, and internationally. Dr. Sharp is a Diplomate of the American Board of Medical Microbiology (ABMM), chair of the American Society for Microbiology’s (ASM’s) Committee on Laboratory Practices, vice-chair of the ABMM, and a member of the editorial board of the Journal of Clinical Microbiology. In 2012, Dr. Sharp was the recipient of the prestigious Sonnenwirth Award for Leadership in Clinical Microbiology.
Jill Taylor, PhD
Interim Director, Wadsworth Center, New York State Department of Health, Albany, New York
Dr. Taylor is Interim Director of the Wadsworth Center, the state of New York’s public health reference laboratory and a premier institution for basic and directed research. She has extensive experience and expertise in public health and laboratory research, particularly related to the prevention and control of infectious diseases. Additionally, she serves as the Director-of-Record for the Wadsworth Center’s clinical laboratory. Prior to assuming the interim directorship, Dr. Taylor held various director and research scientist positions at the Center and served as a senior research scientist at Virogenetics Corporation. At Wadsworth, Dr. Taylor has worked closely with national, state, and local organizations on infectious disease prevention and control. Among her professional activities, she has served and held leadership positions on committees of the Association of Public Health Laboratories.
Robert B. Tesh, MD
Professor of Pathology and of Microbiology and Immunology, University of Texas Medical Branch, Galveston
Dr. Tesh is Professor of Pathology and of Microbiology and Immunology at the University of Texas Medical Branch, where he holds the John S. Dunn Distinguished Chair in Biodefense. He is currently Director of the World Reference Center for Emerging Viruses and Arboviruses. During his long career, he has been involved in both field and laboratory research in the United States and abroad on the epidemiology and pathogenesis of a variety of arthropod-borne and zoonotic viral diseases. A second research interest is virus discovery and characterization of new viral agents. Dr. Tesh previously served as a U.S. Public Health Service physician with the Peace Corps; a research scientist with the National Institute of Allergy and Infectious Diseases, National Institutes of Health; and a member of the faculty of the Department of Epidemiology and Public Health, Yale University School of Medicine.
Judith Nina Wasserheit, MD, MPH
Professor of Medicine and Global Health and Vice Chair, Department of Global Health, University of Washington, Seattle
Dr. Wasserheit is Professor of Medicine and Global Health and Vice Chair of the Department of Global Health at the University of Washington. She has extensive experience in sexually transmitted disease (STD) and HIV research, health policy development, and program implementation in the United States and developing countries. Her work addresses international health priorities and health disparities, and her research interests include the impact of HIV and other STDs on women and adolescents, STD/HIV interactions, HIV vaccine clinical trials, and the impact of climate change on human health. Previous positions include serving as Chief of the newly established Sexually Transmitted Diseases Branch at the National Institutes of Health (NIH), as Director of CDC’s STD prevention division, and as Director of the NIH-funded HIV Vaccine Trials Network. Dr. Wasserheit has served on numerous national and international committees, including her current membership on the NIH Office of AIDS Research Advisory Council. She is a member of the Institute of Medicine of the National Academies; is a Paul G. Rogers Society for Global Health Research Ambassador; and in 2009, was honored as the London School of Hygiene and Tropical Medicine’s Heath Clark Endowed Lecturer. In 2012, she assumed the chair of the Board of Directors of the Consortium of Universities for Global Health.
Robert A. Weinstein, MD
System Chair and Department Chair, Department of Medicine, Cook County Health and Hospitals System and John H. Stroger Jr. Hospital of Cook County, and Chief Operating Officer, Ruth M. Rothstein CORE Center for the Prevention, Care, and Research of Infectious Diseases, Chicago, Illinois
Dr. Weinstein is System Chair and Department Chair of Medicine for the Cook County Health and Hospitals System and at John H. Stroger Jr. Hospital of Cook County and serves as Chief Operating Officer of the Ruth M. Rothstein CORE Center for the Prevention, Care, and Research of Infectious Diseases. His clinical and research interests focus on healthcare-acquired infections (particularly the epidemiology and control of antimicrobial resistance and infections in intensive care units), rapid HIV testing, and healthcare costs and outcomes for healthcare-acquired infections and for patients with HIV/AIDS. Dr. Weinstein is a past president of the Society for Healthcare Epidemiology of America (SHEA) and past chair of CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC). He is also the C. Anderson Hedberg, MD, Professor of Medicine at Rush University Medical College, in Chicago.